Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis By Drug Type
1.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate By Drug Type: 2018 VS 2022 VS 2034
1.2.2 By Drug Type
1.2.3 By Cancer Type
1.3 Market by Application
1.3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Growth by Application: 2018 VS 2022 VS 2034
1.3.2 Lung
1.3.3 Breast
1.3.4 Colorectal
1.3.5 Melanoma
1.3.6 Prostate
1.3.7 Head and Neck
1.3.8 Ovarian
1.3.9 Pancreatic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Perspective (2018-2034)
2.2 Cancer Immunotherapy Drug Discovery Outsourcing Growth Trends by Region
2.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Region (2018-2024)
2.2.3 Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Region (2024-2034)
2.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Dynamics
2.3.1 Cancer Immunotherapy Drug Discovery Outsourcing Industry Trends
2.3.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers
2.3.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Challenges
2.3.4 Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Revenue
3.1.1 Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Revenue (2018-2024)
3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Players (2018-2024)
3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Immunotherapy Drug Discovery Outsourcing Revenue
3.4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio
3.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2022
3.5 Cancer Immunotherapy Drug Discovery Outsourcing Key Players Head office and Area Served
3.6 Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service
3.7 Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Immunotherapy Drug Discovery Outsourcing Breakdown Data by Type
4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Type (2018-2024)
4.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2024-2034)
5 Cancer Immunotherapy Drug Discovery Outsourcing Breakdown Data by Application
5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Application (2018-2024)
5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2018-2034)
6.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Rate by Country: 2018 VS 2022 VS 2034
6.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2018-2024)
6.4 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2018-2034)
7.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Rate by Country: 2018 VS 2022 VS 2034
7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2018-2024)
7.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2018-2034)
8.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Rate by Region: 2018 VS 2022 VS 2034
8.3 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2018-2024)
8.4 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2018-2034)
9.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Rate by Country: 2018 VS 2022 VS 2034
9.3 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2018-2024)
9.4 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2018-2034)
10.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Rate by Country: 2018 VS 2022 VS 2034
10.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2018-2024)
10.4 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aquila BioMedical
11.1.1 Aquila BioMedical Company Detail
11.1.2 Aquila BioMedical Business Overview
11.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.1.4 Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
11.1.5 Aquila BioMedical Recent Development
11.2 BPS Bioscience, Inc.
11.2.1 BPS Bioscience, Inc. Company Detail
11.2.2 BPS Bioscience, Inc. Business Overview
11.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.2.4 BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
11.2.5 BPS Bioscience, Inc. Recent Development
11.3 Celentyx Ltd
11.3.1 Celentyx Ltd Company Detail
11.3.2 Celentyx Ltd Business Overview
11.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.3.4 Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
11.3.5 Celentyx Ltd Recent Development
11.4 Crown Bioscience, Inc.
11.4.1 Crown Bioscience, Inc. Company Detail
11.4.2 Crown Bioscience, Inc. Business Overview
11.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.4.4 Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
11.4.5 Crown Bioscience, Inc. Recent Development
11.5 DiscoverX Corporation
11.5.1 DiscoverX Corporation Company Detail
11.5.2 DiscoverX Corporation Business Overview
11.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.5.4 DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
11.5.5 DiscoverX Corporation Recent Development
11.6 Explicyte
11.6.1 Explicyte Company Detail
11.6.2 Explicyte Business Overview
11.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.6.4 Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
11.6.5 Explicyte Recent Development
11.7 Genscript Biotech Corporation
11.7.1 Genscript Biotech Corporation Company Detail
11.7.2 Genscript Biotech Corporation Business Overview
11.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.7.4 Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
11.7.5 Genscript Biotech Corporation Recent Development
11.8 HD Biosciences Co.
11.8.1 HD Biosciences Co. Company Detail
11.8.2 HD Biosciences Co. Business Overview
11.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.8.4 HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
11.8.5 HD Biosciences Co. Recent Development
11.9 Horizon Discovery Group PLC
11.9.1 Horizon Discovery Group PLC Company Detail
11.9.2 Horizon Discovery Group PLC Business Overview
11.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.9.4 Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
11.9.5 Horizon Discovery Group PLC Recent Development
11.10 ImmunXperts SA
11.10.1 ImmunXperts SA Company Detail
11.10.2 ImmunXperts SA Business Overview
11.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.10.4 ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
11.10.5 ImmunXperts SA Recent Development
11.11 Molecular Imaging, Inc.
11.11.1 Molecular Imaging, Inc. Company Detail
11.11.2 Molecular Imaging, Inc. Business Overview
11.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.11.4 Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
11.11.5 Molecular Imaging, Inc. Recent Development
11.12 Promega Corporation,Personalis, Inc.
11.12.1 Promega Corporation,Personalis, Inc. Company Detail
11.12.2 Promega Corporation,Personalis, Inc. Business Overview
11.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.12.4 Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
11.12.5 Promega Corporation,Personalis, Inc. Recent Development
11.13 STC Biologics
11.13.1 STC Biologics Company Detail
11.13.2 STC Biologics Business Overview
11.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.13.4 STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
11.13.5 STC Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2034
Table 2. Key Players of
Table 3. Key Players of
Table 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2034
Table 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Region (2018-2024)
Table 8. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Region (2024-2034)
Table 10. Cancer Immunotherapy Drug Discovery Outsourcing Market Trends
Table 11. Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers
Table 12. Cancer Immunotherapy Drug Discovery Outsourcing Market Challenges
Table 13. Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints
Table 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Players (2018-2024)
Table 16. Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2022)
Table 17. Ranking of Global Top Cancer Immunotherapy Drug Discovery Outsourcing Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Cancer Immunotherapy Drug Discovery Outsourcing Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service
Table 21. Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2018-2024)
Table 25. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2024-2034)
Table 27. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Application (2018-2024)
Table 29. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Application (2024-2034)
Table 31. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 32. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 35. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 41. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 44. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2024-2034) & (US$ Million)
Table 46. Aquila BioMedical Company Detail
Table 47. Aquila BioMedical Business Overview
Table 48. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 49. Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024) & (US$ Million)
Table 50. Aquila BioMedical Recent Development
Table 51. BPS Bioscience, Inc. Company Detail
Table 52. BPS Bioscience, Inc. Business Overview
Table 53. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 54. BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024) & (US$ Million)
Table 55. BPS Bioscience, Inc. Recent Development
Table 56. Celentyx Ltd Company Detail
Table 57. Celentyx Ltd Business Overview
Table 58. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 59. Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024) & (US$ Million)
Table 60. Celentyx Ltd Recent Development
Table 61. Crown Bioscience, Inc. Company Detail
Table 62. Crown Bioscience, Inc. Business Overview
Table 63. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 64. Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024) & (US$ Million)
Table 65. Crown Bioscience, Inc. Recent Development
Table 66. DiscoverX Corporation Company Detail
Table 67. DiscoverX Corporation Business Overview
Table 68. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 69. DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024) & (US$ Million)
Table 70. DiscoverX Corporation Recent Development
Table 71. Explicyte Company Detail
Table 72. Explicyte Business Overview
Table 73. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 74. Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024) & (US$ Million)
Table 75. Explicyte Recent Development
Table 76. Genscript Biotech Corporation Company Detail
Table 77. Genscript Biotech Corporation Business Overview
Table 78. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 79. Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024) & (US$ Million)
Table 80. Genscript Biotech Corporation Recent Development
Table 81. HD Biosciences Co. Company Detail
Table 82. HD Biosciences Co. Business Overview
Table 83. HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 84. HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024) & (US$ Million)
Table 85. HD Biosciences Co. Recent Development
Table 86. Horizon Discovery Group PLC Company Detail
Table 87. Horizon Discovery Group PLC Business Overview
Table 88. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 89. Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024) & (US$ Million)
Table 90. Horizon Discovery Group PLC Recent Development
Table 91. ImmunXperts SA Company Detail
Table 92. ImmunXperts SA Business Overview
Table 93. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 94. ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024) & (US$ Million)
Table 95. ImmunXperts SA Recent Development
Table 96. Molecular Imaging, Inc. Company Detail
Table 97. Molecular Imaging, Inc. Business Overview
Table 98. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 99. Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024) & (US$ Million)
Table 100. Molecular Imaging, Inc. Recent Development
Table 101. Promega Corporation,Personalis, Inc. Company Detail
Table 102. Promega Corporation,Personalis, Inc. Business Overview
Table 103. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 104. Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024) & (US$ Million)
Table 105. Promega Corporation,Personalis, Inc. Recent Development
Table 106. STC Biologics Company Detail
Table 107. STC Biologics Business Overview
Table 108. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 109. STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024) & (US$ Million)
Table 110. STC Biologics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type: 2022 VS 2034
Figure 3. Features
Figure 4. Features
Figure 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application: 2022 VS 2034
Figure 7. Lung Case Studies
Figure 8. Breast Case Studies
Figure 9. Colorectal Case Studies
Figure 10. Melanoma Case Studies
Figure 11. Prostate Case Studies
Figure 12. Head and Neck Case Studies
Figure 13. Ovarian Case Studies
Figure 14. Pancreatic Case Studies
Figure 15. Cancer Immunotherapy Drug Discovery Outsourcing Report Years Considered
Figure 16. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 17. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 18. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Region: 2022 VS 2034
Figure 19. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Players in 2022
Figure 20. Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2022
Figure 22. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2018-2034)
Figure 24. United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2018-2034)
Figure 28. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. France Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Nordic Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Region (2018-2034)
Figure 36. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. India Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2018-2034)
Figure 44. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Country (2018-2034)
Figure 48. Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 50. Aquila BioMedical Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
Figure 51. BPS Bioscience, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
Figure 52. Celentyx Ltd Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
Figure 53. Crown Bioscience, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
Figure 54. DiscoverX Corporation Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
Figure 55. Explicyte Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
Figure 56. Genscript Biotech Corporation Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
Figure 57. HD Biosciences Co. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
Figure 58. Horizon Discovery Group PLC Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
Figure 59. ImmunXperts SA Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
Figure 60. Molecular Imaging, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
Figure 61. Promega Corporation,Personalis, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
Figure 62. STC Biologics Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2018-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed